Cargando…

Effects of cannabidiol on anandamide levels in individuals with cannabis use disorder: findings from a randomised clinical trial for the treatment of cannabis use disorder

Cannabidiol (CBD) has shown promise in treating psychiatric disorders, including cannabis use disorder – a major public health burden with no approved pharmacotherapies. However, the mechanisms through which CBD acts are poorly understood. One potential mechanism of CBD is increasing levels of anand...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hua, Daniel Ying-Heng, Hindocha, Chandni, Baio, Gianluca, Lees, Rachel, Shaban, Natacha, Morgan, Celia J., Mofeez, Ali, Curran, H. Valerie, Freeman, Tom P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10121552/ https://www.ncbi.nlm.nih.gov/pubmed/37085531 http://dx.doi.org/10.1038/s41398-023-02410-9

Ejemplares similares

Effect of four-week cannabidiol treatment on cognitive function: secondary outcomes from a randomised clinical trial for the treatment of cannabis use disorder
por: Lees, Rachel, et al.
Publicado: (2023)

Which biological and self-report measures of cannabis use predict cannabis dependency and acute psychotic-like effects?
por: Curran, H. Valerie, et al.
Publicado: (2019)

Associations between cigarette smoking and cannabis dependence: A longitudinal study of young cannabis users in the United Kingdom
por: Hindocha, Chandni, et al.
Publicado: (2015)

Acute effects of delta-9-tetrahydrocannabinol, cannabidiol and their combination on facial emotion recognition: A randomised, double-blind, placebo-controlled study in cannabis users
por: Hindocha, Chandni, et al.
Publicado: (2015)

Cannabis based medicines and cannabis dependence: A critical review of issues and evidence
por: Schlag, Anne K, et al.
Publicado: (2021)

Individual and combined effects of cannabis and tobacco on drug reward processing in non-dependent users
por: Hindocha, Chandni, et al.
Publicado: (2017)

Anatomy of a Joint: Comparing Self-Reported and Actual Dose of Cannabis and Tobacco in a Joint, and How These Are Influenced by Controlled Acute Administration
por: Hindocha, Chandni, et al.
Publicado: (2017)

Medicinal use of cannabis based products and cannabinoids
por: Freeman, Tom P, et al.
Publicado: (2019)

Do AKT1, COMT and FAAH influence reports of acute cannabis intoxication experiences in patients with first episode psychosis, controls and young adult cannabis users?
por: Hindocha, Chandni, et al.
Publicado: (2020)

Efficiency of Inhaled Cannabidiol in Cannabis Use Disorder: The Pilot Study Cannavap
por: Cleirec, Grégoire, et al.
Publicado: (2022)

Individual and combined effects of acute delta-9-tetrahydrocannabinol and cannabidiol on psychotomimetic symptoms and memory function
por: Morgan, Celia J. A., et al.
Publicado: (2018)

Behavioral Characterization of the Effects of Cannabis Smoke and Anandamide in Rats
por: Bruijnzeel, Adriaan W., et al.
Publicado: (2016)

Cannabis and cannabidiol use among autistic and non-autistic adults in the UK: a propensity score-matched analysis
por: Hua, Daniel Ying-Heng, et al.
Publicado: (2021)

Cannabis Dampens the Effects of Music in Brain Regions Sensitive to Reward and Emotion
por: Freeman, Tom P, et al.
Publicado: (2017)

Cannabis Contaminants Limit Pharmacological Use of Cannabidiol
por: Montoya, Zackary, et al.
Publicado: (2020)

Investigating the interaction between schizotypy, divergent thinking and cannabis use
por: Schafer, Gráinne, et al.
Publicado: (2012)

The antipsychotic potential of cannabidiol: clinical implications for patients with psychosis and comorbid cannabis use disorder
por: Garel, Nicolas, et al.
Publicado: (2021)

Co-Use, Simultaneous Use, and Mixing of Cannabis and Tobacco: A Cross-National Comparison of Canada and the US by Cannabis Administration Type
por: Chu, Alanna, et al.
Publicado: (2023)

Acute memory and psychotomimetic effects of cannabis and tobacco both ‘joint’ and individually: a placebo-controlled trial
por: Hindocha, C., et al.
Publicado: (2017)

The CannTeen Study: Cannabis use disorder, depression, anxiety, and psychotic-like symptoms in adolescent and adult cannabis users and age-matched controls
por: Lawn, Will, et al.
Publicado: (2022)

Editorial: Psychological Aspects of Cannabis Use and Cannabis Use Disorder
por: Feingold, Daniel, et al.
Publicado: (2021)

The neuropsychopharmacology of cannabis: A review of human imaging studies
por: Bloomfield, Michael A.P., et al.
Publicado: (2019)

The International Cannabis Toolkit (iCannToolkit): a multidisciplinary expert consensus on minimum standards for measuring cannabis use
por: Lorenzetti, Valentina, et al.
Publicado: (2021)

The Use of Cannabis for Headache Disorders
por: Lochte, Bryson C., et al.
Publicado: (2017)

Vaping of Cannabis, Cannabidiol, and Synthetic Cannabis Among US Sexual Minority Youths
por: Liu, Jessica, et al.
Publicado: (2023)

Acute and chronic effects of cannabinoids on effort-related decision-making and reward learning: an evaluation of the cannabis ‘amotivational’ hypotheses
por: Lawn, Will, et al.
Publicado: (2016)

The relationship of cannabis decriminalization in Colorado and cannabis use in individuals with alcohol use disorders
por: Hua, Jeremy T., et al.
Publicado: (2020)

Assessing the adaptive role of cannabidiol (CBD) in Cannabis sativa defense against cannabis aphids
por: MacWilliams, Jacob, et al.
Publicado: (2023)

Cannabis Use, Cannabis Use Disorder, and Comorbid Psychiatric Illness: A Narrative Review
por: Hasin, Deborah, et al.
Publicado: (2020)

Cannabidiol reverses attentional bias to cigarette cues in a human experimental model of tobacco withdrawal
por: Hindocha, Chandni, et al.
Publicado: (2018)

No Smoke without Tobacco: A Global Overview of Cannabis and Tobacco Routes of Administration and Their Association with Intention to Quit
por: Hindocha, Chandni, et al.
Publicado: (2016)

Relationships between age at first substance use and persistence of cannabis use and cannabis use disorder
por: Millar, Seán R., et al.
Publicado: (2021)

A “Good” Smoke? The Off-Label Use of Cannabidiol to Reduce Cannabis Use
por: Fortin, Davide, et al.
Publicado: (2022)

AKT1 genotype moderates the acute psychotomimetic effects of naturalistically smoked cannabis in young cannabis smokers
por: Morgan, C J A, et al.
Publicado: (2016)

The acute effects of cannabis with and without cannabidiol in adults and adolescents: A randomised, double‐blind, placebo‐controlled, crossover experiment
por: Lawn, Will, et al.
Publicado: (2023)

Medical cannabis and cannabidiol: A new harvest for Malawi
por: Bandawe, Gama
Publicado: (2022)

Efficacy of Cannabidiol for Δ-9-Tetrahydrocannabinol-Induced Psychotic Symptoms, Schizophrenia, and Cannabis Use Disorders: A Narrative Review
por: Bartoli, Francesco, et al.
Publicado: (2021)

Disentangling longitudinal relations between youth cannabis use, peer cannabis use, and conduct problems: developmental cascading links to cannabis use disorder
por: Defoe, Ivy N., et al.
Publicado: (2018)

Does cannabidiol make cannabis safer? A randomised, double-blind, cross-over trial of cannabis with four different CBD:THC ratios
por: Englund, Amir, et al.
Publicado: (2022)

Attentional bias in adults with cannabis use disorders
por: Vujanovic, Anka A., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_vnogibi2cvciav3t53v83ctat0